Boyds is a dynamic and rapidly growing global drug development consultancy focused on providing specialist consultancy services to an international client base, supporting the development of new, cutting-edge medicines for patient benefit.
Working with pharma companies, early-stage biotechs, medical device companies and universities, the team supports the development of cell and gene therapies, small molecules, biologics and orphan drugs across a wide range of therapeutic areas.
The team has expertise in program management and product development, pharmaceutical due diligence, clinical operations, medical monitoring, regulatory affairs and strategy, medical writing, regulatory operations and provides scientific and medical advice to facilitate the translation of ideas into medicines.
The company was founded in 2005 by Professor Alan Boyd and now has offices in Pennsylvania, Cambridge, Crewe, and Dublin. In 2018, Boyds was awarded the prestigious Queen’s Award for Enterprise, International Trade in recognition for its international work, and in particular its support in the development of gene therapies for the treatment of rare diseases.
Speak to our team of experts
Our team of experts provides a wide range of expertise and skills central to the development of pharmaceutical and biotechnology medicinal products and medical devices.